The Evidence Speaks (January 2023)
The first Evidence Speaks of 2023 features mask mandate effectiveness, client preferences for iOAT delivery, and patient-reported outcomes following hysterectomy
Read MoreAugust 3, 2022
The first Evidence Speaks of 2023 features mask mandate effectiveness, client preferences for iOAT delivery, and patient-reported outcomes following hysterectomy
Read More
CHÉOS Scientists are leading three of the projects funded in this round, plus a further eleven projects are supported by CHÉOS Scientists as co-investigators.
Read More
This edition includes preparing patients for colorectal surgery, exome sequencing's impact on health care utilization, and cardiovascular events in people with glomerular diseases
Read More
Research highlights the gap in perioperative stroke care and addresses what needs to be done to improve patient care
Read More
To mark Heart Month, this edition includes clinical outcomes after TAVR, scene-access delay and patient outcomes after cardiac arrest, and chest pain after an arterial tear in the heart
Read More
As Program Head of Health Services and Outcomes at CHÉOS, Dr. Jason Sutherland studies approaches to allocating funding as a way to improve value from health care
Read More
CHÉOS Scientists and their work on cardiovascular disease, wait-times for hip fracture repair, and colorectal surgery could be found in the media this August
Read More
Dr. Jason Sutherland was recently appointed to the MSFHR Research Leaders Forum, a group that advises MSFHR leadership on the challenges and opportunities affecting health research.
Read More
In August, four CHÉOS Scientists were officially appointed to faculty positions at the University of British Columbia School of Population and Public Health.
Read More
CHÉOS researchers were interviewed about moral distress, patient engagement, health economics, and more in March.
Read More